Ryuji Matsumoto

10PUBLICATIONS
57CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersDisease surveillanceHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 08, 2026
Solitary Fibrous Tumor With Doege-Potter Syndrome Successfully Treated With Preoperative Transcatheter Arterial Embolization and Complete Excision; A Case Report.

Rei Narimatsu, Ryuji Matsumoto, Haruka Miyata

|Aug 11, 2025
Prostatic Stromal Sarcoma With SMARCA4 Mutation: A Case Report.

Kenjiro Kato, Hiromi Kanno-Okada, Ryuji Matsumoto

|Jul 29, 2025
[177Lu]Lu-PSMA-617 in Patients with Progressive PSMA+ mCRPC Treated With or Without Prior Taxane-Based Chemotherapy: A Phase 2, Open-Label, Single-Arm Trial in Japan.

Kouji Izumi, Ryuji Matsumoto, Yusuke Ito

|Apr 08, 2025
Active Surveillance in Prostate Cancer With Intermediate-Risk Features: The PRIAS-JAPAN Study.

Leandro Blas, Masaki Shiota, Takuma Kato

|Dec 07, 2023
TAS0313 plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint Inhibitor-Naïve Locally Advanced or Metastatic Urothelial Carcinoma.

Hiroyuki Nishiyama, Junji Yonese, Takashi Kawahara

|Dec 21, 2022
Editorial Comment to "A national questionnaire survey of Japanese urologists on active surveillance for low- and intermediate-risk prostate cancer".

Ryuji Matsumoto

Pageof 2

Frequent Collaborators

2 joint publications

Naoya Iwahara

2 joint publications

Akira Yokomizo

2 joint publications

Nobuaki Matsubara

1 joint publications

Kanta Hori